Special Report: "Where We Stand: Social Media, Pharma, and the Online Discussion"

Source: HC Marketplace

Click here to read more and order a copy of the report.

ePharmaceuticals' special report, Where We Stand: Social Media, Pharma, and the Online Discussion takes an in-depth look at the different ways pharmaceutical companies can engage in social media, the most common pitfalls and roadblocks, and innovative partnerships. There's also a discussion with PatientsLikeMe and biopharma UCB, which are partnering to create an online patient community, complete with a pharmacovigilance platform.

Where We Stand: Social Media, Pharma, and the Online Discussion will help you:

• Learn where to start when exploring social media and what you should be doing now
• Assess the pros and cons of branded versus unbranded efforts
• Understand the real implications of adverse events on social media
• Discover tailored ways to listen to consumers
• Define social media, not just in a basic way, but within your own company’s priorities
• Uncover missed opportunities

The report features commentary and advice from experts at:

• PatientsLikeMe
• UCB
• Google
• WebMD
• Nielsen Online
• Pew Internet & American Life Project
• Bridge Worldwide
• Ignite Health

For pharma, the social media question is no longer "whether" they should invest, but "how." Where We Stand: Social Media, Pharma, and the Online Discussion will help answer that question.

Click here to read more and order a copy of the report.